Crossject Logo

Crossject

ISIN: FR0011716265 | Ticker: ALCJ | LEI: 969500W1VTFNL2D85A65
Sector: Health CareSub-Industry: Health Care Equipment
Country: France

About Crossject

Company Description

Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®.
ZENEO® is no less than 12 years of R&D and more than 400 obtained patents.

Currently, 8 treatments are in advanced stages of development, which 7 for emergency situations.
With its unique know-how, Crossject aims to become a world leader in the self-administration of emergency needle free injectables.

Year founded

2001

Served area

Worldwide

Headcount

100

Headquarters

Parc Mazen-Sully 6 Rue Pauline Kergomard, 21000 Dijon – France

Insider Trades

Date Trading entity / Person Association Trade type Volume
14.06.24 None Other Other EUR 20,289.19
06.06.24 None Other Other EUR 1,956,324.22
06.06.24 None Other Other EUR 29,763.89
06.06.24 None Other Other EUR 18,988.20
06.06.24 None Other Other EUR 18,616.75
06.06.24 None Other Buy EUR 10,230.53
06.03.23 None Other Other EUR 75,434.70

Capital markets information

ISIN

FR0011716265

LEI

969500W1VTFNL2D85A65

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.